Retatrutide (GLP-3RT) — investigational triple GIP/GLP-1/glucagon receptor co-agonist. The most comprehensive incretin agonist in preclinical research. 10mg lyophilized, HPLC verified.
Retatrutide is a synthetic peptide triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. Developed by Eli Lilly, it represents the most comprehensive incretin pharmacology in a single compound — adding glucagon receptor agonism to the dual approach of Tirzepatide.
The 10mg format is suited for pilot studies, single-experiment protocols, or researchers beginning their investigation of triple agonist pharmacology before committing to the 30mg format for extended research.
For a full breakdown of the research literature, read our Retatrutide research guide →
CoreVionRX doesn’t manufacture peptides. What we do — rigorously — is verify every batch before it reaches our catalog.
Everything you need to evaluate this compound for your research protocol.
| Specification | Value |
|---|---|
| Compound | Retatrutide (GLP-3RT) |
| Class | Triple receptor co-agonist |
| Receptor Targets | GIP receptor (GIPR), GLP-1 receptor (GLP-1R), Glucagon receptor (GcgR) |
| Form | Lyophilized powder |
| Vial Size | 10mg per vial |
| Purity | ≥98% by reversed-phase HPLC |
| Identity | Confirmed by electrospray ionization mass spectrometry |
| Storage (lyophilized) | −20°C, protected from light and moisture |
| Storage (reconstituted) | 2–8°C, away from light |
| Documentation | Lot-specific COA with HPLC chromatogram — included with every order |
All published research is preclinical — cell cultures and animal models. No human clinical trial data exists for Retatrutide. Here’s where the science currently stands.
Jastreboff AM. et al. (2023) N Engl J Med 389(6):514-26
Samms RJ. et al. (2023) Cell Metab 35(9):1517-33
Coskun T. et al. (2022) Mol Metab 66:101634
Most peptide vendors claim purity. We document it. Every compound ships with independent lab verification — not because regulations require it, but because you deserve to know exactly what you’re working with.
In stock. COA included. HPLC + mass spec verified. Ships with full documentation.
For laboratory research use only. Not for human or animal consumption.
CoreVionRX supplies research compounds to qualified laboratories and research institutions.
Documentation & Testing Standards
Every batch is independently tested before release. Research peptide FAQs · CoreVionRX testing standards
Related Research Compounds